Voyager Acquisition Corp./Cayman Islands
VACH$270M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaHOUSTON
Drugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
VACH News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
VP4896
Alzheimer's Disease
Leuprolide acetate
Alzheimer Disease
VY7523
Alzheimer's Disease (AD)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
VP4896 | Phase 3 | Alzheimer's Disease | - | - |
Leuprolide acetate | Phase 2 | Alzheimer Disease | - | - |
VY7523 | Phase 2 | Alzheimer's Disease (AD) | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply